GB2108387B - A pharmaceutical composition containing myeloperoxidase - Google Patents

A pharmaceutical composition containing myeloperoxidase

Info

Publication number
GB2108387B
GB2108387B GB8233109A GB8233109A GB2108387B GB 2108387 B GB2108387 B GB 2108387B GB 8233109 A GB8233109 A GB 8233109A GB 8233109 A GB8233109 A GB 8233109A GB 2108387 B GB2108387 B GB 2108387B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
composition containing
containing myeloperoxidase
myeloperoxidase
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8233109A
Other versions
GB2108387A (en
Inventor
Eichi Hasegawa
Takashi Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GREEN CROSS CORP
Mitsubishi Tanabe Pharma Corp
Original Assignee
GREEN CROSS CORP
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP17210979A external-priority patent/JPS5696694A/en
Priority claimed from JP2211380A external-priority patent/JPS56118018A/en
Priority claimed from GB8026907A external-priority patent/GB2066260B/en
Application filed by GREEN CROSS CORP, Green Cross Corp Japan filed Critical GREEN CROSS CORP
Publication of GB2108387A publication Critical patent/GB2108387A/en
Application granted granted Critical
Publication of GB2108387B publication Critical patent/GB2108387B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/02—Oxidoreductases acting on a peroxide as acceptor (1.11) with H2O2 as acceptor, one oxygen atom of which is incorporated into the product (1.11.2)
    • C12Y111/02002—Myeloperoxidase (1.11.2.2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB8233109A 1979-12-28 1982-11-19 A pharmaceutical composition containing myeloperoxidase Expired GB2108387B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP17210979A JPS5696694A (en) 1979-12-28 1979-12-28 Separation of myeloperoxidase from human nyelogenic leukocite
JP2211380A JPS56118018A (en) 1980-02-22 1980-02-22 Drug composition containing myeloperoxidase as main constituent
GB8026907A GB2066260B (en) 1980-08-18 1980-08-18 Method for recovering myeloperoxidase and a pharmaceutical composition containg it

Publications (2)

Publication Number Publication Date
GB2108387A GB2108387A (en) 1983-05-18
GB2108387B true GB2108387B (en) 1984-03-21

Family

ID=27260994

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8233109A Expired GB2108387B (en) 1979-12-28 1982-11-19 A pharmaceutical composition containing myeloperoxidase

Country Status (1)

Country Link
GB (1) GB2108387B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS592686A (en) * 1982-06-25 1984-01-09 Green Cross Corp:The Powder pharmaceutical preparation of myeloperoxidase
US5460961A (en) * 1988-06-14 1995-10-24 La Region Wallonne Human myeloperoxidase and its therapeutic application
FR2632525B1 (en) * 1988-06-14 1992-07-31 Improbio THERAPEUTIC APPLICATION OF HUMAN MYELOPEROXYDASE
US5846799A (en) * 1988-06-14 1998-12-08 La Region Wallone Human myeloperoxidase and its therapeutic application
US5389369A (en) * 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
US5565197A (en) * 1991-02-21 1996-10-15 Exoxemis, Inc. Method which utilizes a haloperoxidase composition to inhibit the growth of microorganisms which cause sexually transmitted diseases
AU663869B2 (en) 1991-02-21 1995-10-26 Exoxemis, Inc. Methods and compositions for the treatment of infection and control of flora
US5756090A (en) 1991-02-21 1998-05-26 Eoe, Inc. Oxygen activatable formulations for disinfection or sterilization
US5888505A (en) * 1991-02-21 1999-03-30 Eoe, Inc. Method for selectively inhibiting the growth of microbes using a haloperoxidase-halide-peroxide system
US8945540B2 (en) 2008-05-09 2015-02-03 Exoxemis, Inc. Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
MX2013015084A (en) 2011-07-11 2014-02-11 Exoxemis Inc Eosinophil peroxidase compositions and methods of their use.
AU2017269582B2 (en) 2016-05-27 2023-12-21 Exoxemis, Inc. Myeloperoxidase compositions and methods for inhibition of lipopolysaccharides and lipid A

Also Published As

Publication number Publication date
GB2108387A (en) 1983-05-18

Similar Documents

Publication Publication Date Title
GB2046092B (en) Pharmaceutical composition containing a lysophospholid and a phospholipid
GB2039738B (en) Inflammation - preventing pharmaceutical composition
GB2020655B (en) Pharmaceutical compounds
GB2108387B (en) A pharmaceutical composition containing myeloperoxidase
ZA83130B (en) A pharmaceutical composition
GB2077100B (en) Pharmaceutical compositions containing cromoglycates
GB2048671B (en) Pharmaceutical composition containing dihydroegotoxine
ZA802009B (en) Pharmaceutical compounds
JPS55392A (en) Muramyllpeptide type novel compounds and drug containing them
NZ192021A (en) Pharmaceutical compositions containing aryltrifluoroethanols
JPS54154516A (en) Pharmaceutical composition
JPS5527168A (en) Drug composition
JPS55123199A (en) Containing case
JPS56127311A (en) Novel medicine composition
GB2028130B (en) Pharmaceutical wound-treating compositions containing allantoin
JPS5587718A (en) Medicine composition
ZA81919B (en) Pharmaceutical compositions containing a naphyridine derivative
JPS54147911A (en) Pharmaceutical composition containing nnacetylmulaminate glycohydrorase
IE792439L (en) Pharmaceutical composition containing a thiazolidine¹derivative
GB2049416B (en) Pharmaceutical composition
IL57881A (en) Pharmaceutical compositions containing benzamidoalkyl merccaptans
JPS55108816A (en) Pharmaceutical composition containing benzimidazolee2 derivative
JPS5699415A (en) Medicinal composition
JPS54122736A (en) Pharmaceutical composition
PH14593A (en) A pharmaceutical composition incorporating an aryltrifluoroethanol

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee